Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium

Journal of Immunology

Volumn 168, Issue 10, 2002, Pages 5240-5251

  D'Hauteville, Hélène ^a   Khan, Shahid ^a   Maskell, Duncan J ^a   Kussak, Anders ^a   Weintraub, Andrej ^a   Mathison, John ^a   Ulevitch, Richard J ^a   Wuscher, Nicole ^a   Parsot, Claude ^a   Sansonetti, Philippe J ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; GLUCOSAMINE; LIPID A; MYRISTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CHROMOSOME; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; MONOCYTE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RABBIT; SHIGELLA FLEXNERI;

EID: 0037094025     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.10.5240     Document Type: Article

References (69)

1. Shigella vaccines
2. Global burden of Shigella infections: Implications for vaccine development and implementation of vaccine strategies
3. Involvement of a plasmid in the invasive ability of Shigella flexneri
4. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri
5. Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella: Making sense of prokaryote-eukaryote cross talks
6. IpaB mediates apoptosis induced by Shigella flexneri
7. A bacterial invasin induces macrophage apoptosis by binding directly to ICE
8. Infection of rabbit Peyer's patches by Shigella flexneri: Effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium
9. Role of interleukin-1 in the pathogenesis of shigellosis
10. Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental shigellosis
11. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation
12. Invasive Shigella flexneri activates NF-κB through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells
13. CARD4/Nodl mediates NF-κB and JNK activation by invasive Shigella flexneri
14. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion
15. Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry
16. Innate immune responses of epithelial cells following infection with bacterial pathogens
17. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis
18. Toll signaling pathways in the innate immune response
19. Human Nod-l confers responsiveness to bacterial lipopolysaccharides
20. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction
21. Function of the htrb high temperature requirement gene of Escherichia coli in the acylation of lipid a: HtrB-catalyzed incorporation of laurate
22. A novel Escherichia coli lipid A mutant that produces an anti-inflammatory lipopolysaccharide
23. Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A
24. icsB: A Shigella flexneri virulence gene necessary for the lysis of protrusions during intracellular spread
25. Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants
26. A novel suicide vector and its use in construction of insertion mutations: Osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR
27. Construction of an eae deletion mutant of enteropathogenc Escherichia coli by using a positive selection suicide vector
28. A correction in the nucleotide sequence of the Tn903 kanamycin resistance determinant in pUC4K
29. pACYC184-derived cloning vectors containing the multiple cloning site and lacZ α reporter gene of pUC8/9 and pUC18/19 plasmids
30. Extraction with phenol-water and further applications of the procedure
31. The humoral antibody response to Bacteroides fragilis infections in humans
32. Protein measurement with the folin phenol reagent
33. Multiplication of Shigella flexneri within HeLa cells: Lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis
34. Plaque formation by virulent Shigella flexneri
35. Experimental keratoconjunctivitis shigellosa
36. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis
37. Alteration in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri
38. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin
39. A highly sensitive cell line. WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
40. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide
41. Detailed structural characterization of lipid A: Electrospray ionization coupled with tandem-mass spectrometry
42. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein
43. Biochemistry of endotoxins
44. The lipopolysaccharide of Shigella bacteria as a virulence factor
45. Shigella lipopolysaccharide: Structure, genetics and vaccine development
46. Effect of mutations in Shigella chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance
47. Virulence-associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis
48. Interleukin-1 is released by murine macrophages during apoptosis induced by Shigella flexneri
49. Bacterial endotoxin: Molecular relationships of structure to activity and function
50. Immunobiological activities of synthetic lipid A analogs with low endotoxicity
51. Endotoxins and disease mechanisms
52. Mutation of the htrB gene in a virulent Salmonella typhimurium strain by intergeneric transduction: Strain construction and phenotypic characterization
53. A lethal role for lipid A in Salmonella infections
54. Escherichia coli msbB gene as a virulence factor and a therapeutic target
55. Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis
56. Effect of O-side chain length and composition on the virulence of Shigella flexneri 2a
57. Lipopolysaccharide from an Escherichia coli htrB msbB mutant induces high levels of MIP-1α and MIP-1β secretion without inducing TNF-α and IL-1β
58. Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis
59. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
60. Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes
61. The complete DNA sequence and analysis of the large virulence plasmid of Escherichia coli O157:H7
62. Complete nucleotide sequence of 93-kb and 3.3-kb plasmids of an enterohemorrhagic Escherichia coli O157:H7 derived from Sakai outbreak
63. Complete DNA sequence and structural analysis of the enteropathogenic Escherichia coli adherence factor plasmid
64. Escherichia coli: EAEC, EHEC, EIEC, ETEC
65. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ
66. Small bowel enteropathy: Role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-γ, TNF) in the induction of epithelial cell death and renewal
67. Treatment of Crohn's disease with antitumor necrosis factor chimeric monoclonal antibody (cA2)
68. Concentrations of interleukin 6 and tumor necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection
69. Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602